& Cambridge, MA About Blog ProMIS ™ Neurosciences, Inc., is a development stage biotech company that discovers and develops precision therapeutics and companion diagnostics for early detection and
effective treatment of neurodegenerative diseases, in particular Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS).
research; since most of the reports have concentrated on justifying the creation of cloned human embryos for research into and
treatment of neurodegenerative diseases such as Parkinson's, «stem - cells» has become synonymous with «embryonic stem - cells» in the public imagination.
In addition to serving as the attending neurosurgical clinician at the Veterinary Medical Teaching Hospital, he was an active researcher for the development
of treatments of neurodegenerative disease that affect both young dogs and children.
A new study stirs up debate over a long - held finding, and could dim hopes for the treatment of neurodegenerative diseases
(Moussa is listed as an inventor on a patent application that Georgetown University filed related to nilotinib and the use of other tyrosine kinase inhibitors for
the treatment of neurodegenerative diseases.)
This finding is the latest from Georgetown University Medical Center's Translational Neurotherapeutics Program (TNP) examining tyrosine kinase inhibitors in
the treatment of neurodegenerative diseases.
Georgetown has filed a patent application related to use of certain DDR inhibitors for
the treatment of neurodegenerative diseases.
A new review examines the potential of antioxidant approaches for
the treatment of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and multiple sclerosis.
Scientists, therefore, hope to deploy them as agents in
the treatment of neurodegenerative diseases.
Long - term goal of the project will be to visualize and manipulate tau expression also in a systemic context (organotypic slice preparations, mouse brain) by affecting the function of tau mRNA - containing neuronal granules as a potential drug target for
the treatment of neurodegenerative diseases.
From a clinical perspective, Jessell's findings have paved the way for
the treatment of neurodegenerative diseases, notably spinal muscular atrophy and Lou Gehrig's disease.
Neurotrophic factors have been pursued as appealing candidates for
the treatment of neurodegenerative diseases, neuropathies and peripheral nerve injury [118, 119].
His work is focused on the understanding and
treatments of neurodegenerative disease, with particular emphasis on distinguishing critical mechanisms...
Several other compounds are also in early - stage development for
the treatment of neurodegenerative diseases caused by protein aggregation.
His work is focused on the understanding and
treatments of neurodegenerative disease, with particular emphasis on distinguishing critical mechanisms and treatments of neuronal vulnerability at the onset of disease, or new restorative treatments using stem cells after symptoms.
Moussa is an inventor on a Georgetown University patent application for use of nilotinib for
the treatment of neurodegenerative disease.
Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in
the treatment of neurodegenerative disease.
The funds will support the development of NurOwn ®, BrainStorm's innovative MSC - based platform for
the treatment of neurodegenerative diseases.
This course explores the causes and
treatments of neurodegenerative diseases, as well as common conditions such as depression, anxiety, sleep disorders, and the like.